An In Vitro Assay of β-Galactosidase from Yeast by Stefan Schneider, Michael Buchert, Christopher M. Hovens

Get full text

The Prostate Cancer Immune Microenvironment, Biomarkers and Therapeutic Intervention by Yangyi Zhang, Bethany K. Campbell, Stanley S. Stylli, Niall M. Corcoran, Christopher M. Hovens

Get full text

Perish and publish: Dynamics of biomedical publications by deceased authors. by Chol-Hee Jung, Paul C Boutros, Daniel J Park, Niall M Corcoran, Bernard J Pope, Christopher M Hovens

Get full text

Sodium selenate as a disease-modifying treatment for mild–moderate Alzheimer’s disease: an open-label extension study by Lucy Vivash, Dennis Velakoulis, Terence J O’Brien, Charles B Malpas, Amy Brodtmann, Christopher M Hovens, Steven Collins, Stephen Macfarlane

Get full text

Curated microRNAs in urine and blood fail to validate as predictive biomarkers for high-risk prostate cancer. by Nikhil Sapre, Matthew K H Hong, Geoff Macintyre, Heather Lewis, Adam Kowalczyk, Anthony J Costello, Niall M Corcoran, Christopher M Hovens

Get full text

An immune suppressive tumor microenvironment in primary prostate cancer promotes tumor immune escape. by Angelyn Anton, Ryan Hutchinson, Christopher M Hovens, Michael Christie, Andrew Ryan, Peter Gibbs, Anthony Costello, Justin Peters, Paul J Neeson, Niall M Corcoran, Ben Tran

Get full text

Author Correction: Inferring structural variant cancer cell fraction by Marek Cmero, Ke Yuan, Cheng Soon Ong, Jan Schröder, PCAWG Evolution and Heterogeneity Working Group, Niall M. Corcoran, Tony Papenfuss, Christopher M. Hovens, Florian Markowetz, Geoff Macintyre, PCAWG Consortium

Get full text

A study protocol for a phase II randomised, double-blind, placebo-controlled trial of sodium selenate as a disease-modifying treatment for behavioural variant frontotemporal dement... by Rebekah M Ahmed, Lucy Vivash, Dennis Velakoulis, Leonid Churilov, Olivier Piguet, David Darby, Terence J O'Brien, Charles B Malpas, Mark Walterfang, Amy Brodtmann, Ashley I Bush, Christopher M Hovens, T Kalincik

Get full text

A phase 1b open‐label study of sodium selenate as a disease‐modifying treatment for possible behavioral variant frontotemporal dementia by Lucy Vivash, Charles B. Malpas, Christian Meletis, Meghan Gollant, Dhamidhu Eratne, Qiao‐Xin Li, Stuart McDonald, William T. O'Brien, Amy Brodtmann, David Darby, Christopher Kyndt, Mark Walterfang, Christopher M. Hovens, Dennis Velakoulis, Terence J. O'Brien

Get full text

Phase II randomised placebo-controlled trial of sodium selenate as a disease-modifying treatment in chronic drug-resistant temporal lobe epilepsy: the SeLECT study protocol by Lucy Vivash, Dennis Velakoulis, Patrick Carney, Patrick Kwan, Leonid Churilov, Terence J O’Brien, Christopher M Hovens, Nicholas Lawn, Piero Perucca, Sandy R Shultz, John-Paul Nicolo, Charles Malpas, Manori Wijayath, David Reutens, Hannah Johns, Sara MacPhail, Pablo Casillas-Espinosa, Chris Tailby, Lisa Gillinder

Get full text

Sodium selenate as a disease-modifying treatment for progressive supranuclear palsy: protocol for a phase 2, randomised, double-blind, placebo-controlled trial by Kelly L Bertram, Lucy Vivash, Dennis Velakoulis, Leonid Churilov, Thomas Kimber, David Darby, Terence J O’Brien, Charles B Malpas, Christopher M Hovens, Simon J G Lewis, Joanne Fielding, Andrew H Evans, Stephen Tisch, John D O’Sullivan, Ian H Harding, Meaghan Clough, Cassandra Marotta, Scott Kolbe, Meng Law

Get full text